Tobacco Cessation at FDNY
Launched by ALBERT EINSTEIN COLLEGE OF MEDICINE · Aug 10, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Tobacco Cessation at FDNY trial is studying a new approach to help firefighters and other participants in the FDNY World Trade Center Health Program quit smoking. Many of these individuals are current smokers, even though they have been referred to a standard tobacco cessation program. The trial will compare the usual care with an Enhanced Care program that offers personalized counseling based on lung health tests and starts medication to help quit smoking about a month before the planned quit date.
To be eligible for this study, participants need to be at least 50 years old, retired, and currently smoking or have smoked within the last five years. They should also have a significant smoking history. However, individuals with certain health issues, like severe kidney problems or those currently being treated for cancer, cannot participate. If chosen for the study, participants will receive tailored support to help them quit smoking, which could improve their chances of success in becoming smoke-free.
Gender
ALL
Eligibility criteria
- • Inclusion
- • Enrolled in FDNY WTCHP
- • Retired
- • Age ≥ 50 years old
- • Self-reported current smoker on most recent questionnaire OR self-reported current smoker in the past 5 years
- • 20 pack-year smoker OR 20-year smoking duration
- • Exclusion
- • Reduced renal function\*
- • estimated glomerular filtration rate (eGFR) \<30 \[CKD-EPI Creatinine Equation (2021)\] at last WTC medical monitoring blood exam OR ICD10 codes for kidney disease: N04.9, N17.9, N18.9, Z94.0, E13.21, N18.9, I12.9, N00.9, N03.9
- • Undergoing active cancer treatment, defined as being diagnosed on 1/1/2022 or later
- • Clinical instability (e.g., hospitalization in last 3 months)
- • Using varenicline in last 30 days†
- • Endorsing suicidal ideations: moderate or high risk on C-SSRS
- • Screened for alcohol use disorder AUDIT\>15
About Albert Einstein College Of Medicine
Albert Einstein College of Medicine is a leading academic institution dedicated to advancing biomedical research and medical education. Situated in the Bronx, New York, it is renowned for its commitment to innovative research and training the next generation of physicians and scientists. The college actively engages in a wide range of clinical trials, focusing on translating scientific discoveries into effective therapies and improving patient care. With a collaborative approach that involves multidisciplinary teams, Albert Einstein College of Medicine aims to address significant health challenges and contribute to the global medical community through rigorous research and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brooklyn, New York, United States
Patients applied
Trial Officials
Shadi Nahvi, MD, MS
Principal Investigator
Albert Einstein College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported